|
SGH-200 Glycohemoglobin Analyzer – Fast and Accurate HbA1c Testing Solution
In diabetes management, turnaround time is infrastructure. A device that cuts HbA1c results to under three minutes doesn’t just add convenience — it reshapes patient flow in crowded outpatient settings.
The SGH-200 Glycohemoglobin Analyzer is a low-footprint diagnostic system targeting a common bottleneck: the lag between blood draw and clinical decision. Designed to handle both venous and fingertip samples, it accepts just 5 µL of blood and returns aligned IFCC and NGSP values in under three minutes.
That dual-standard reporting is not a technical footnote. It reflects the device’s role in a globalizing diagnostics supply chain — where labs in China must output data readable by US and European protocols without secondary conversion. The SGH-200 removes that step.
Its compact form factor and support for fingertip samples suggest it is built as much for primary care clinics as tertiary hospitals. In contexts where lab infrastructure is thin, the ability to bypass venipuncture and run tests on-site directly changes screening capacity.
The SGH-200 is not a flagship innovation; it is an integration play. It packages established ion-exchange HPLC or boronate affinity chemistry into a standardized workflow that reduces operator training and per-test cost. That makes it a procurement candidate for provincial health bureaus scaling chronic disease programs.
Why it matters:
For operators, the SGH-200 compresses a 15-minute lab round-trip into a single consultation window. For suppliers, it signals a shift toward distributed, low-operator-variance diagnostics — exactly the kind of device needed to extend HbA1c screening to county-level China.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.